PLMO-02 - Plenary session – Innovative drug discovery and access



Prof. Ross Mckinnon, Chairman of the FIP Board of Pharmaceutical Sciences and Dr Rebecka Isaksson, FIP Scientific Secretary


This plenary session on innovative drug discovery and access will address current challenges, integrating industry-driven innovation with patient-centric clinical trials. A panel discussion titled, “Pharmacy’s role in bridging the gap,” will discuss new clinical trial models, innovative drug discoveries post-COVID-19 pandemic, and the role of pharmacists in improving access to groundbreaking medicines. It will showcase successful collaborations and recent breakthroughs in drug discovery.


Faculty confirmed:

  • Prof. Marc Blockman, South African Health Products Regulatory Authority (SAHPRA), South Africa, South Africa
  • Prof. Yahya Choonara University of The Witwatersrand, South Africa
  • Dr Timothy Hanlon, Ministry of Health, New Zealand
  • Prof. Sarel Malan, School of Pharmacy, University of Western Cape Town, South Africa
  • Dr Boitumelo Semete-Makototlela, South African Health Products Regulatory Authority (SAHPRA), South Africa